Reductions in the cost of whole-genome sequencing (WGS) and whole-exome sequencing (WES) are opening the door to affordable sequencing of patients and the development of precision medicine 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback